US 12053519
HIV-1 Env fusion peptide nanoparticle carrier conjugates and their use
granted A61KA61K2039/55544A61K2039/55555
Quick answer
US patent 12053519 (HIV-1 Env fusion peptide nanoparticle carrier conjugates and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/55544, A61K2039/55555, A61K2039/6031, A61K2039/6037